HSBC Holdings
NAGE

HSBC Holdings’s Niagen Bioscience NAGE Stock Holding History

HSBC Holdings’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-28,057
Closed -$136K – 3188
2020
Q4 		$136K Buy
28,057
+990
+4% +$4.83K ﹤0.01% 2904
2020
Q3 		$109K Hold
27,067
– – ﹤0.01% 2612
2020
Q2 		$124K Buy
27,067
+6,026
+29% +$27K ﹤0.01% 2483
2020
Q1 		$67K Buy
+21,041
New +$80.8K ﹤0.01% 2524

Other funds holding NAGE

YRHAM
Yong Rong (HK) Asset Management Sheung Wan, Hong Kong $227M AUM 300.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

HSBC Holdings's NAGE Position: Q1 2021 in Review

HSBC Holdings sold out of Niagen Bioscience (NAGE) in Q1 2021, closing a stake of 28,057 shares — an estimated $136K sold.

HSBC Holdings first reported a position in NAGE in Q1 2020 and held it in 4 quarters. The position peaked at $136K in Q4 2020. 96 funds tracked by Wall St. Rank hold NAGE as of Q1 2021.

  • HSBC Holdings reported no remaining Niagen Bioscience position as of Q1 2021 after selling out during the quarter.
  • HSBC Holdings sold 28,057 Niagen Bioscience shares in Q1 2021, an estimated $136K.
  • HSBC Holdings first reported a position in Niagen Bioscience in Q1 2020 and held it in 4 quarters.
  • HSBC Holdings's Niagen Bioscience position peaked at $136K in Q4 2020.
  • 96 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2021.

Based on HSBC Holdings's 13F filing for Q1 2021, filed 14 May 2021.